Chord Energy just posted its August results and rallied through them, yet short sellers responded by rebuilding positions at the fastest weekly pace in months — a split signal worth watching closely.
The short-interest reversal is sharp and recent. Shares short jumped 27% in a single session on August 11, pushing the SI figure to 6.4% of the free float — up from a recent trough closer to 5.1% that preceded the earnings print. Over the full week, shorts grew by 23%. That reversal is notable because the prior note documented a month-long unwind; shorts had been cutting positions steadily from the mid-July peak of around 3.65 million shares. Now they're back above that level at 3.63 million. The ORTEX short score jumped accordingly, moving from roughly 41-42 through the prior week to 46.1 on August 11 — its highest reading in the recent window. That said, the borrow market doesn't back up any squeeze narrative. Availability is extraordinarily loose at nearly 2,000% — meaning lenders hold roughly twenty shares for every one currently borrowed. Cost to borrow is just 0.46%, down 12% on the week despite the surge in short positions. The options market is equally unperturbed: the put/call ratio is 0.74, barely a third of a standard deviation above its 20-day average. Shorts are rebuilding, but they are doing so cheaply and without urgency.
The Street remains broadly bullish, though the trend in targets has been downward for most of the summer. UBS raised its target to $171 this week — a meaningful move from $153 — while maintaining its Buy. Truist trimmed modestly to $166 from $170, also keeping its Buy. Those two moves largely offset each other directionally. Morgan Stanley and Citigroup both cut targets in late June and early July, and Citigroup's Neutral at $130 is the clearest bearish outlier on the panel. The consensus mean sits at $167, implying roughly 20% upside from the current $139.23. Valuation confirms the cheap read: EV/EBITDA is running at 3.2x with the 30-day trend rising, price-to-book is below one at 0.86x, and the earnings yield factor ranks in the 72nd percentile. The bull case centres on CHRD's scale as the only pure-play Williston Basin E&P, its 4-mile lateral program, and what the Street characterises as an underappreciated franchise relative to proven developed producing NAV. The bear case is more macro — commodity price and rate sensitivity — rather than a structural critique of the business.
Institutional ownership tells a supportive story. BlackRock holds 12.9% of shares and added 115,000 shares in July. Wellington Management built a position of nearly 3.8 million shares, adding 1.97 million over the most recent period. FMR and Invesco both added in July as well. That level of active institutional accumulation provides a structural counterweight to any short-side pressure. Insider activity cuts the other way: Director Douglas Brooks sold 8,000 shares on August 7 for just over $1 million, and the CFO sold shares in March. Net insider flow over 90 days is modestly positive at roughly $1.8 million, but that's almost entirely a function of timing rather than conviction buying — there are no purchases in the recent trades list.
On the peer side, the week's energy move was broad. PR, OVV, SM, and COP all gained 4-7% on the week. APA led the group up 13%. CHRD's 1.7% weekly gain lagged the peer set noticeably — which is itself worth flagging given that the stock was the earnings-week outperformer last week before shorts rebuilt. The relative underperformance against closely correlated names like PR and OVV could reflect post-earnings profit-taking, the short rebuild, or simply a rotation within the E&P group toward names with more commodity beta.
The next catalyst is the November 4 earnings date, which leaves a long stretch for the positioning picture to evolve — the key question between now and then is whether this week's short rebuild represents fresh conviction or a temporary repositioning that unwinds as oil prices and the stock recover ground lost relative to peers.
See the live data behind this article on ORTEX.
Open CHRD on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
